SBIR/STTR Research Award

Convenient rapid and portable tool for the detection of ribonucleases

Award identifier 836dfa13ae1555368fc242b3d51897b5fb99534a4cfce14688f590bb202f468eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$229,975

Program and phase

SBIR · Phase I

Award year

2023

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ATTOGENE CORPORATION
Proposal award date
2023-09-01
Contract end date
2024-08-31
UEI
M5VSPH6FK6D6
Solicitation number
PA22-176
Topic code
400

Research abstract

Summary/AbstractThe past decade has brought an escalating growth of important new commercial applications for RNA. RNA molecules have emerged as the preeminent regulators of gene expression. They have a unique ability to edit genomes and destabilize gene products. New diagnostic applications for RNA are continually being discovered. Last but not least, modified mRNA nanoparticle formulations are enabling the development of new vaccines and cellular therapies with a speed and efficacy unrivaled by other processes. This newfound success has driven increased interest and efforts in many areas of RNA research. Researchers are constantly discovering important new roles for RNA in the regulation of cellular processes. It has also opened the door to many new commercial opportunities for startups and large pharmaceutical and diagnostic companies alike. Accordingly, massive effort is now directed to production scale-up and large-scale manufacturing of RNA molecules. As production increases, there is a far greater need for care and control of manufacturing processes. This is especially true for RNA since it is quite vulnerable to degradation by contaminating enzymes in the surrounding environment.As production scales and costs increase, more attention must be paid to strict process control and quality management. For example, manufacturing of RNA for regulated therapeutic and diagnostic applications must be performed in a certified RNAse-free environment. Current commercial methods to verify the absence of RNAse require expensive equipment and hours to perform. The cost and time required to perform RNAse testing hinders the productivity of manufacturers and researchers alike. A new rapid tool to test for unwanted RNA contamination would great assist researchers and manufacturers who must frequently test their environments and supply chain materials.In Phase I, we will create a novel prototype lateral flow test for the sensitive detection of RNAse. Our work will produce a test kit product with several important advantages over currently available tools: Convenience: Our test will be portable and not require bulky, expensive lab equipment. Sensitivity: Our test will be at least 5-times more sensitive than current methods. Time: Users will see their results in less than 15 minutes rather than hours. These combined advantages of our proposed product will create a highly effective tool to further support the continuing innovation in RNA therapeutics and research. Specific Aim #1: Optimize the incubation buffer and RNA oligonucleotide sequence to improve RNAse assay sensitivity. Specific Aim #2: Produce a more sensitive fluorescent version of the lateral flow RNAse detection assay. Specific Aim #3: Enable testing of solid surfaces using swab wipes.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

7 SBIR/STTR records share this UEI (2019–2025). Reported award amounts total $1,565,137. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services, National Science Foundation, Department of Commerce

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.